Location History:
- Zürich, CH (2014)
- Zurich, CH (2016 - 2022)
Company Filing History:
Years Active: 2014-2025
Title: Duncan E Paterson: Innovator in Oligosaccharide-Protein Conjugates
Introduction
Duncan E Paterson is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the development of oligosaccharide-protein conjugates. With a total of 5 patents to his name, Paterson's work has implications for pharmaceutical compositions and treatments for lysosomal storage disorders.
Latest Patents
Paterson's latest patents focus on oligosaccharide-protein conjugates. These patents detail conjugates that comprise a protein and an oligosaccharide of specific formulae. Additionally, they describe pharmaceutical compositions that include these conjugates. The methods outlined in his patents aim to treat lysosomal storage disorders in mammals through the administration of oligosaccharide-glycoprotein conjugates.
Career Highlights
Duncan E Paterson is currently associated with Genzyme Corporation, a company known for its innovative approaches in biotechnology. His work at Genzyme has allowed him to further explore the potential of oligosaccharide-protein conjugates in medical applications.
Collaborations
Throughout his career, Paterson has collaborated with esteemed colleagues, including Luis Z Avila and Clark Qun Pan. These collaborations have contributed to the advancement of research in his field.
Conclusion
Duncan E Paterson's contributions to the field of oligosaccharide-protein conjugates highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the biochemistry landscape and offers hope for advancements in treating lysosomal storage disorders.